Literature DB >> 3130177

Branhamella catarrhalis septicemia in patients with leukemia.

H Saito1, E J Anaissie, N Khardori, G P Bodey.   

Abstract

During a 10-year period, four patients with leukemia were identified who had Branhamella catarrhalis septicemia. Two patients had acute leukemia and the remaining two had chronic myelogenous leukemia with blastic transformation. All patients were febrile and neutropenic at the onset of the septicemia. After appropriate antibiotic therapy, they recovered from their infection despite persistence of neutropenia. Because beta-lactamase-producing bacteria are an increasing cause of nosocomial infections, treatment should be selected to cover them.

Entities:  

Mesh:

Year:  1988        PMID: 3130177     DOI: 10.1002/1097-0142(19880601)61:11<2315::aid-cncr2820611128>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature.

Authors:  J Collazos; J de Miguel; R Ayarza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 2.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

Authors:  T F Murphy
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 3.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 4.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.